Abbott Laboratories (BIT:1ABT)

Market Cap	164.06B -23.3%
Revenue (ttm)	37.75B +5.7%
Net Income	5.56B -51.3%
EPS	3.17 -51.3%
Shares Out	n/a
PE Ratio	29.53
Forward PE	19.66
Dividend	2.15 (2.27%)
Ex-Dividend Date	Jan 14, 2026

Volume	103
Average Volume	286
Open	93.42
Previous Close	93.24
Day's Range	93.42 - 94.37
52-Week Range	88.92 - 120.94
Beta	n/a
RSI	40.87
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 115,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ABT

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD